DYSLIPIDEMIA

Lipoprotiens

• Lipoprotein

Types of Dyslipidemia

• Primary Dyslipidemia
• Secondary Dyslipidemia
• ASCVD

Screening & Management

• Screening Dyslipidemia

• Dyslipidemia Management Guidelines

  • Primary prevention of Dyslipidemia
    • People Without CHD
    • Preventing first event
    • Is beneficial for reducing CV morbidity and mortality
  • Secondary prevention of Dyslipidemia
    • People with history of ASCVD.
    • Trials have shown the largest benefit in mortality and CV events.
  • Lipid Lowering Medications

• CS-dyslipidemia & Dyslipidemia Refrences

Dyslipidemia

• Dyslipidemia, defined as elevated lipids (total cholesterol, low-density lipoprotein (LDL) levels, Triglyceride one or all), or decreased levels of high-density lipoprotein (HDL) cholesterol.

• Is an important risk factor for coronary heart disease (CHD) and stroke.

• Detected by laboratory tests, and usually occurs without signs or symptoms.

• These disorders can be primary or secondary.

Content

• Basics of lipids in the body.
• Definition of Dyslipidemia.
• Types of Dyslipidemia.
• ASCVD Risk Factor.
• Screening.
• Dyslipidemia Management Guidelines.
• Guidelines for DLP Prevention.
• Dyslipidemia treatment.

Objectives

• Screen appropriate patients for hyperlipidemia.
• Take an appropriate history, examine and test the patient for modifiable causes.
• Treat hyperlipidemia patients, and establish target lipid levels based on overall CV risk.
• Give appropriate lifestyle and dietary advice.